Insights into the Association Between QSER1 and M2 Macrophages and Remarkable Malignancy Characteristics in Hepatocellular Carcinoma

被引:2
|
作者
Wu, Min [1 ]
Shi, Qi-man [1 ]
Duan, Sai-Li [1 ]
Ou-yang, Deng-jie [1 ]
Chen, Pei [1 ]
Tu, Biao [1 ]
Huang, Peng [1 ]
机构
[1] Cent South Univ, Dept Gen Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
HCC; QSER1; prognosis; immune infiltration; GENE-EXPRESSION; CANCER; PROGNOSIS; HEPATITIS; BIOMARKERS; LANDSCAPE; FIBROSIS;
D O I
10.2147/IJGM.S352574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Glutamine and serine rich 1 (QSER1), as a DNA methylation modulator, play a crucial role in transforming tumor cells. Previous studies have shown that QSER1 plays a role in regulating the progression of various malignancies and that QSER1 dysfunction is connected with precancerous lesions of hepatocellular carcinoma (HCC) as well as HCC prognosis. However, little is known about the detailed contribution of QSER1 in HCC. Patients and Methods: Various statistical methods such as Kaplan-Meier method, AUC analysis, GSEA, and immune-infiltration analysis were used to evaluate the relationship between QSER1 expression and clinical features, prognostic factors, and potential functional mechanisms of QSER1. Results: QSER1 expression was negatively correlated with clinicopathological features (clinical stage, pathological grade, TP53 mutation, lymph node metastasis) and clinical outcome (overall survival versus recurrence). Functional enrichment analysis further suggested that QSER1 is involved in multiple pathways related to DNA replication and tumor immunity. TIMER analysis indicated that high QSER1 expression was significantly associated with higher macrophage infiltration and poorer macrophage-related outcomes. In particular, QSER1 was significantly more associated with M2 macrophages than M1 macrophages. Conclusion: Overall, elevated QSER1 is a potential prognostic marker for HCC and is associated with immune infiltration in HCC.
引用
收藏
页码:1765 / 1775
页数:11
相关论文
共 50 条
  • [31] An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate - An institutional study
    Hadimani, Soumya M.
    Das, Subhashish
    Harish, K. G.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S300 - S305
  • [32] d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
    Han, Shulan
    Bao, Xueying
    Zou, Yifang
    Wang, Lingzhi
    Li, Yutong
    Yang, Leilei
    Liao, Anqi
    Zhang, Xuemei
    Jiang, Xin
    Liang, Di
    Dai, Yun
    Zheng, Qing-Chuan
    Yu, Zhuo
    Guo, Jianfeng
    SCIENCE ADVANCES, 2023, 9 (29)
  • [33] Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma (vol 62, pg 607, 2015)
    Yeung, Oscar W. H.
    Lo, Chung-Mau
    Ling, Chang-Chun
    Qi, Xiang
    Geng, Wei
    Li, Chang-Xian
    Ng, Kevin T. P.
    Forbes, Stuart J.
    Guan, Xin-Yuan
    Poon, Ronnie T. P.
    Fan, Sheung-Tat
    Man, Kwan
    JOURNAL OF HEPATOLOGY, 2016, 64 (06) : 1461 - 1461
  • [34] Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages
    Zhang, Zhihao
    Zhang, Jingwen
    He, Ping
    Han, Jingjing
    Sun, Changyu
    MOLECULAR IMMUNOLOGY, 2020, 122 : 13 - 20
  • [35] Evaluation of M2 macrophages with multiplex immunohistochemistry in triple-negative breast carcinoma: the association with response to neoadjuvant chemotherapy
    Li, Zaibo
    Nitta, Hiro
    Banks, Peter
    Parwani, Anil
    LABORATORY INVESTIGATION, 2019, 99
  • [36] Evaluation of M2 macrophages with multiplex immunohistochemistry in triple-negative breast carcinoma: the association with response to neoadjuvant chemotherapy
    Li, Zaibo
    Nitta, Hiro
    Banks, Peter
    Parwani, Anil
    MODERN PATHOLOGY, 2019, 32
  • [37] Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis (vol 124, pg 359, 2014)
    Osinska, I
    Wolosz, D.
    Domagala-Kulawik, J.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2014, 124 (09): : 490 - 490
  • [38] M2 tumor-associated macrophages produce interleukin-17 to suppress oxaliplatin-induced apoptosis in hepatocellular carcinoma
    Guo, Bin
    Li, Leilei
    Guo, Jiapei
    Liu, Aidong
    Wu, Jinghua
    Wang, Haixin
    Shi, Jun
    Pang, Dequan
    Cao, Qing
    ONCOTARGET, 2017, 8 (27) : 44465 - 44476
  • [39] Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression
    Qingcan Sun
    Mengying Shen
    Subin Zhu
    Yanxia Liao
    Dongyan Zhang
    Jingyuan Sun
    Zeqin Guo
    Leyuan Wu
    Lushan Xiao
    Li Liu
    Hepatology International, 2023, 17 : 1444 - 1460
  • [40] Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression
    Sun, Qingcan
    Shen, Mengying
    Zhu, Subin
    Liao, Yanxia
    Zhang, Dongyan
    Sun, Jingyuan
    Guo, Zeqin
    Wu, Leyuan
    Xiao, Lushan
    Liu, Li
    HEPATOLOGY INTERNATIONAL, 2023, 17 (06) : 1444 - 1460